Track the Expres2ion Biotech Holding AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Expres2ion Biotech Holding AB has recorded 4 reports. Market capitalisation: €15.3m. The latest transaction was filed on 1 July 2026 (Purchase). Among the most active insiders: Bent Frandsen. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Expres2ion Biotech Holding AB is a company focused on developing biopharmaceutical solutions. It specializes in the production of recombinant proteins for therapeutic applications.